UG1CA189957
Cooperative Agreement
Overview
Grant Description
Dayton clinical oncology program.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Dayton,
Ohio
454592633
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 07/31/19 to 07/31/27 and the total obligations have increased 1154% from $855,000 to $10,724,562.
Dayton Clinical Oncology Program was awarded
Dayton Clinical Oncology Program
Cooperative Agreement UG1CA189957
worth $10,724,562
from National Cancer Institute in August 2014 with work to be completed primarily in Dayton Ohio United States.
The grant
has a duration of 13 years and
was awarded through assistance program 93.399 Cancer Control.
The Cooperative Agreement was awarded through grant opportunity NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required).
Status
(Ongoing)
Last Modified 9/21/26
Period of Performance
8/1/14
Start Date
7/31/27
End Date
Funding Split
$10.7M
Federal Obligation
$0.0
Non-Federal Obligation
$10.7M
Total Obligated
Activity Timeline
Transaction History
Modifications to UG1CA189957
Additional Detail
Award ID FAIN
UG1CA189957
SAI Number
UG1CA189957-3096661703
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NC00 NIH National Cancer Institute
Funding Office
75NC00 NIH National Cancer Institute
Awardee UEI
YGVQGKAQ7577
Awardee CAGE
477S3
Performance District
OH-10
Senators
Sherrod Brown
J.D. (James) Vance
J.D. (James) Vance
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $8,125,990 | 100% |
Modified: 9/21/26